Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hyperhomocysteinemia: an additional cardiovascular risk factor.

P C Fanapour1, B Yug, M S Kochar

  • 1Medical College of Wisconsin, USA.

WMJ : Official Publication of the State Medical Society of Wisconsin
|January 20, 2000
PubMed
Summary

High homocysteine levels (hyperhomocysteinemia) are a significant cardiovascular disease risk factor. Supplementing with folate and vitamin B6 may help manage homocysteine, but long-term studies are needed to confirm cardiovascular benefits.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The need to lower systolic blood pressure.

Current hypertension reports·2000
Same author

Management of postural hypotension.

Current hypertension reports·2000
Same author

Hypertension in women.

WMJ : official publication of the State Medical Society of Wisconsin·2000
Same author

Effect of pain and nonsteroidal analgesics on blood pressure.

WMJ : official publication of the State Medical Society of Wisconsin·1999
Same author

What is causing your patient's sexual dysfunction? Uncovering a connection with hypertension and antihypertensive therapy.

Postgraduate medicine·1999
Same author

Clinical pharmacology & therapeutics.

WMJ : official publication of the State Medical Society of Wisconsin·1999

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Nutritional Science

Background:

  • Hyperhomocysteinemia, elevated homocysteine levels, is a recognized risk factor for cardiovascular diseases (CVD).
  • Deficiencies in methylenetetrahydrofolate reductase, vitamin B6, or folate impair homocysteine metabolism.
  • High coffee consumption can also elevate homocysteine levels.

Purpose of the Study:

  • To review the evidence linking hyperhomocysteinemia to cardiovascular disease.
  • To discuss the mechanisms by which homocysteine may exert its adverse effects.
  • To highlight the potential role of folate and vitamin B6 in managing hyperhomocysteinemia and preventing CVD.

Main Methods:

  • Literature review of studies on hyperhomocysteinemia and cardiovascular disease.

Related Experiment Videos

  • Analysis of biochemical pathways involved in homocysteine metabolism.
  • Examination of proposed mechanisms for homocysteine-induced vascular damage.

    • Main Results:

    • Hyperhomocysteinemia is associated with increased risk of myocardial infarction, atherosclerosis, coronary heart disease, and cerebrovascular disease.
    • Homocysteine may damage endothelial cells, promote plaque formation, impair nitric oxide function, and induce vascular smooth muscle cell hypertrophy.
    • Its risk is comparable to hypercholesterolemia and smoking, with potential multiplicative effects with other risk factors.

    Conclusions:

    • Maintaining normal homocysteine levels through folate and vitamin B6 intake is a promising strategy for CVD prevention.
    • Further long-term prospective studies are required to definitively establish the efficacy of folate and vitamin B6 in reducing CVD morbidity and mortality in hyperhomocysteinemic individuals.